AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 8,765.10
+36.60 (0.42%)
At close: Aug 8, 2025
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 219.13 billion as of August 8, 2025. Its market cap has increased by 23.87% in one year.
Market Cap
219.13B
Enterprise Value
214.12B
Revenue
17.16B
Ranking
n/a
PE Ratio
189.33
Stock Price
8,765.10
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 219.13B, an increase of 15,012.24%. That is a compound annual growth rate of 23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 219.13B | 19.91% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | 115.54B | 76.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 18.51T |
| HDFC Bank | 15.15T |
| Bharti Airtel | 11.15T |
| Tata Consultancy Services | 10.99T |
| ICICI Bank | 10.25T |
| State Bank of India | 7,424.19B |
| Infosys | 5,899.00B |
| Hindustan Unilever | 5,870.69B |